Topharman Shanghai Co., Ltd., established in 2008, manufactures chiral pharmaceutical intermediates, with a product line centered on quinolinone-based building blocks used in aripiprazole synthesis (including 7-hydroxy-2(1H)-quinolinone, 7-(4-bromobutoxy)quinolin-2(1H)-one, and 1-benzo[b]thien-4-yl-piperazine hydrochloride) as well as related benzofuran derivatives. The company sells its intermediates across North America, Central and South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét